Long-term Acyclovir Suppression of Frequently Recurring Genital Herpes Simplex Virus Infection: A Multicenter Double-blind Trial

JAMA: The Journal of the American Medical Association

Volumn 260, Issue 2, 1988, Pages 201-206

  Mertz, Gregory J ^a   Jones, Clifton C ^a   Mills, John ^b   Fife, Kenneth H ^c   Lemon, Stanley M ^d   Stapleton, Jack T ^d   Hill, Edgar L ^e   Davis, L Gray ^e  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e Burroughs Wellcome Co   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR;

CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; GENITAL HERPES; HUMAN; MAJOR CLINICAL STUDY; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ACYCLOVIR; ADULT; CLINICAL TRIALS; DOUBLE-BLIND METHOD; FEMALE; HERPES GENITALIS; HUMAN; MALE; MICROBIAL SENSITIVITY TESTS; RANDOM ALLOCATION; RECURRENCE; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0023909951     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1988.03410020067030     Document Type: Article

References (24)

1. Mertz GJ, Critchlow CW, Benedetti J, et al.: Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection. JAMA 1984;252:1147-1151.
2. Bryson YJ, Dillon M, Lovett M, et al.: Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir: A randomized doubleblind controlled trial in normal subjects. N Engl J Med 1983;308:916-921.
3. Reichman RC, Badger GJ, Mertz GJ, et al.: Treatment of recurrent genital herpes simplex infections with oral acyclovir: A controlled trial. JAMA 1984;251:2103-2107.
4. Douglas JM, Critchlow C, Benedetti J, et al.: A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection. N Engl J Med 1984;310:1551-1556.
5. Straus SE, Takiff HE, Seidlin M, et al.: Suppression of frequently recurring genital herpes: A placebo-controlled double-blind trial of oral acyclovir. N Engl J Med 1984;310:1545-1550.
6. Mindel A, Weller IVD, Faherty A, et al.: Prophylactic oral acyclovir in recurrent genital herpes. Lancet 1984;2:57-59.
7. Portnoy J, Taussig A: A double blind placebo controlled six month trial of prophylactic oral acyclovir in recurrent genital herpes, abstract 185. Read before the 32nd General Assembly of the International Union Against Venereal Diseases and Treponematosis, Montreal, June 20,1984.
8. Thin RN, Jeffries DJ, Taylor PK, et al.: Recurrent genital herpes suppressed by oral acyclovir: A multicentre double-blind trial. J Antimicrob Chemother 1985;16:219-226.
9. Blom I, Bäck O, Egelrud T, et al.: Long-term oral acyclovir treatment prevents recurrent genital herpes. Dermatologica 1986;173:220-223.
10. Halsos AM, Salo OP, Lassus A, et al.: Oral acyclovir suppression of recurrent genital herpes: A double-blind, placebo-controlled crossover study. Acta Derm Venerol 1985;65:59-63.
11. Kinghorn GR, Jeavons M, Rowland M, et al.: Acyclovir prophylaxis of recurrent genital herpes: Randomized placebo controlled crossover study. Genitourin Med 1985;61:387-390.
12. Sacks SL, Fox R, Levendusky P, et al.: Chronic suppression for six months compared with intermittent lesional therapy of recurrent genital herpes using oral acyclovir: Effects on lesions and nonlesional prodromes. Sex Transm Dis 1988;15:58-62.
13. Nusinoff Lehrman S, Douglas JM, Corey L, et al.: Recurrent genital herpes and suppressive oral acyclovir therapy: Relation between clinical outcome and in-vitro drug sensitivity. Ann Intern Med 1986;104:786-790.
14. Wentworth BB, Bonin P, Holmes KK, et al.: Isolation of viruses, bacteria and other organisms from venereal disease clinic patients: Methodology and problems associated with multiple isolations. Health Lab Sci 1973;10:75-81.
15. Quinn RP, deMiranda P, Gerald L, et al.: A sensitive radioimmunoassay for the antiviral agent BW248U[9-(2-hydroxyethoxymethyl) guanine]. Anal Biochem 1979;98:319-328.
16. Mertz GJ, Eron L, Kaufman R, et al.: Prolonged continuous vs intermittent oral acyclovir treatment in normal adults with frequently recurring genital herpes simplex virus infections. Am J Med, in press.
17. Frenkel L, Pineda E, Garratty E, et al.: A year long prospective study of the effects of acyclovir treatment on the lymphocyte proliferation response to HSV type 2 antigens of persons with frequently recurring genital HSV-2 infections, abstracted. Clin Res 1986;34:517A.
18. Erlich KS, Hauer L, Mills J: Effects of long-term acyclovir chemosuppression on serum IgG antibody to herpes simplex virus. J Med Virol, in press.
19. Corey L, Holmes KK, Benedetti J, et al.: Clinical course of genital herpes: Implications for clinical trials, in Nahmias AJ, Dowdle WR, Schinazi RF (eds): The Human Herpesviruses: An Interdisciplinary Perspective. New York, Elsevier Science Publishing Co Inc, 1981, pp 496-502.
20. Brown ZA, Kern ER, Spruance SL, et al.: Clinical and virologic course of herpes simplex genitalis. West J Med 1979;130:414-421.
21. Corey L, Nahmias AJ, Guinan ME, et al.: A trial of topical acyclovir in genital herpes simplex virus infections. N Engl J Med 1982;306:1313-1319.
22. Gold D, Corey L: Acyclovir prophylaxis for herpes simplex virus infection. Antimicrob Agents Chemother 1987;31:361-367.
23. Mertz GJ: Diagnosis and treatment of genital herpes infections. Infect Dis Clin North Am 1987;1:341-366.
24. Mindel A, Foherty A, Carney O, et al.: Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes. Lancet 1988;1:926-928.